Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System

NCT04089371 is registered in ClinicalTrials.gov with Stryker Trauma and Extremities as lead sponsor.

NCT NCT04089371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04089371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System
Lead sponsor
Stryker Trauma and Extremities
Phase
Observational
Overall status
Terminated
Start date
October 1, 2019
Completion date
July 8, 2022
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, hemiarthroplasty, shoulder pain